We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0J7G market cap is 0. The company's latest EPS is USD and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 204.89M | 227.98M | 356.13M | 428.24M | 838M |
| Operating Income | -144.69M | -196.67M | -328.32M | -405.75M | 14.7M |
| Net Income | -106.02M | -125.73M | -194.65M | -360.84M | 100.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 465.12M | 724.12M | 1.37B | 1.03B | 1.28B |
| Total Liabilities | 152.22M | 205.17M | 333.15M | 392.58M | 536.39M |
| Total Equity | 312.9M | 518.95M | 1.04B | 636.87M | 743.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -80.91M | -62.07M | -204.22M | -268.6M | 219.26M |
| Investing | 119.03M | -125.44M | -306.32M | 296.59M | -291.14M |
| Financing | -1.49M | 296.43M | 650.03M | -82.76M | 48.66M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 37 |
| Average Volume (1 Month) | 535 |
| 52 Week Change | 0.00% |
| 52 Week High | 33.29 |
| 52 Week Low | 33.29 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Hutchison China Meditech Ltd |
| Address |
po box 309 grand cayman KY1 1104 |
| Website | https://www.hutch-med.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
